Stay updated on Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Sign up to get notified when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.

Latest updates to the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe Publications section now states that PubMed publications are automatically filled from PubMed and may not all be about the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check35 days agoChange DetectedRemoved the government funding and operating status banner from the study page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedStudy status updated to Terminated; enrollment difficulties arose as patients opted for ovarian ablation to obtain insurance reimbursement, making them ineligible for participation.SummaryDifference0.4%

- Check78 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%

- Check85 days agoChange DetectedUpdate: version tag updated from v3.0.2 to v3.1.0. The page now indicates the newer release.SummaryDifference0.1%

- Check99 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the Back to Top element was removed. Core content, pricing, stock, and time-slot data remain unchanged.SummaryDifference0.2%

Stay in the know with updates to Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumasiran in Primary Hyperoxaluria Type 1 Infants/Young Children Clinical Trial page.